Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 70

Cited In for PubMed (Select 18400866)

1.

Central role for PICALM in amyloid-β blood-brain barrier transcytosis and clearance.

Zhao Z, Sagare AP, Ma Q, Halliday MR, Kong P, Kisler K, Winkler EA, Ramanathan A, Kanekiyo T, Bu G, Owens NC, Rege SV, Si G, Ahuja A, Zhu D, Miller CA, Schneider JA, Maeda M, Maeda T, Sugawara T, Ichida JK, Zlokovic BV.

Nat Neurosci. 2015 Jul;18(7):978-87. doi: 10.1038/nn.4025. Epub 2015 May 25.

PMID:
26005850
2.

Resetting the transcription factor network reverses terminal chronic hepatic failure.

Nishikawa T, Bell A, Brooks JM, Setoyama K, Melis M, Han B, Fukumitsu K, Handa K, Tian J, Kaestner KH, Vodovotz Y, Locker J, Soto-Gutierrez A, Fox IJ.

J Clin Invest. 2015 Apr;125(4):1533-44. doi: 10.1172/JCI73137. Epub 2015 Mar 16.

3.

High capsid-genome correlation facilitates creation of AAV libraries for directed evolution.

Nonnenmacher M, van Bakel H, Hajjar RJ, Weber T.

Mol Ther. 2015 Apr;23(4):675-82. doi: 10.1038/mt.2015.3. Epub 2015 Jan 14.

PMID:
25586687
4.

Gene delivery to adipose tissue using transcriptionally targeted rAAV8 vectors.

Uhrig-Schmidt S, Geiger M, Luippold G, Birk G, Mennerich D, Neubauer H, Grimm D, Wolfrum C, Kreuz S.

PLoS One. 2014 Dec 31;9(12):e116288. doi: 10.1371/journal.pone.0116288. eCollection 2014.

5.

Antibody neutralization poses a barrier to intravitreal adeno-associated viral vector gene delivery to non-human primates.

Kotterman MA, Yin L, Strazzeri JM, Flannery JG, Merigan WH, Schaffer DV.

Gene Ther. 2015 Feb;22(2):116-26. doi: 10.1038/gt.2014.115. Epub 2014 Dec 11.

6.

Inhibiting the oncogenic mir-221 by microRNA sponge: toward microRNA-based therapeutics for hepatocellular carcinoma.

Moshiri F, Callegari E, D'Abundo L, Corrà F, Lupini L, Sabbioni S, Negrini M.

Gastroenterol Hepatol Bed Bench. 2014 Winter;7(1):43-54.

7.

Improving clinical efficacy of adeno associated vectors by rational capsid bioengineering.

Sen D.

J Biomed Sci. 2014 Nov 26;21:103. doi: 10.1186/s12929-014-0103-1.

8.

Adeno-associated virus serotype 1 (AAV1)- and AAV5-antibody complex structures reveal evolutionary commonalities in parvovirus antigenic reactivity.

Tseng YS, Gurda BL, Chipman P, McKenna R, Afione S, Chiorini JA, Muzyczka N, Olson NH, Baker TS, Kleinschmidt J, Agbandje-McKenna M.

J Virol. 2015 Feb;89(3):1794-808. doi: 10.1128/JVI.02710-14. Epub 2014 Nov 19.

PMID:
25410874
9.

Promoterless gene targeting without nucleases ameliorates haemophilia B in mice.

Barzel A, Paulk NK, Shi Y, Huang Y, Chu K, Zhang F, Valdmanis PN, Spector LP, Porteus MH, Gaensler KM, Kay MA.

Nature. 2015 Jan 15;517(7534):360-4. doi: 10.1038/nature13864. Epub 2014 Oct 29.

PMID:
25363772
10.

Novel adeno-associated viruses derived from pig tissues transduce most major organs in mice.

Bello A, Chand A, Aviles J, Soule G, Auricchio A, Kobinger GP.

Sci Rep. 2014 Oct 22;4:6644. doi: 10.1038/srep06644.

11.

Intracerebroventricular viral injection of the neonatal mouse brain for persistent and widespread neuronal transduction.

Kim JY, Grunke SD, Levites Y, Golde TE, Jankowsky JL.

J Vis Exp. 2014 Sep 15;(91):51863. doi: 10.3791/51863.

PMID:
25286085
12.

Synthetic virology: engineering viruses for gene delivery.

Guenther CM, Kuypers BE, Lam MT, Robinson TM, Zhao J, Suh J.

Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2014 Nov-Dec;6(6):548-58. doi: 10.1002/wnan.1287. Epub 2014 Sep 4. Review.

PMID:
25195922
13.

Gene therapy for the nervous system: challenges and new strategies.

Maguire CA, Ramirez SH, Merkel SF, Sena-Esteves M, Breakefield XO.

Neurotherapeutics. 2014 Oct;11(4):817-39. doi: 10.1007/s13311-014-0299-5.

PMID:
25159276
14.

Systemic gene delivery to the central nervous system using Adeno-associated virus.

Bourdenx M, Dutheil N, Bezard E, Dehay B.

Front Mol Neurosci. 2014 Jun 2;7:50. doi: 10.3389/fnmol.2014.00050. eCollection 2014. Review.

15.

Naturally enveloped AAV vectors for shielding neutralizing antibodies and robust gene delivery in vivo.

György B, Fitzpatrick Z, Crommentuijn MH, Mu D, Maguire CA.

Biomaterials. 2014 Aug;35(26):7598-609. doi: 10.1016/j.biomaterials.2014.05.032. Epub 2014 Jun 7.

PMID:
24917028
16.

Engineering adeno-associated viruses for clinical gene therapy.

Kotterman MA, Schaffer DV.

Nat Rev Genet. 2014 Jul;15(7):445-51. doi: 10.1038/nrg3742. Epub 2014 May 20. Review.

17.

Young blood reverses age-related impairments in cognitive function and synaptic plasticity in mice.

Villeda SA, Plambeck KE, Middeldorp J, Castellano JM, Mosher KI, Luo J, Smith LK, Bieri G, Lin K, Berdnik D, Wabl R, Udeochu J, Wheatley EG, Zou B, Simmons DA, Xie XS, Longo FM, Wyss-Coray T.

Nat Med. 2014 Jun;20(6):659-63. doi: 10.1038/nm.3569. Epub 2014 May 4.

18.

Adeno-associated viral serotypes produce differing titers and differentially transduce neurons within the rat basal and lateral amygdala.

Holehonnur R, Luong JA, Chaturvedi D, Ho A, Lella SK, Hosek MP, Ploski JE.

BMC Neurosci. 2014 Feb 18;15:28. doi: 10.1186/1471-2202-15-28.

19.

Adeno-associated virus structural biology as a tool in vector development.

Drouin LM, Agbandje-McKenna M.

Future Virol. 2013 Dec;8(12):1183-1199.

20.

Mapping the AAV Capsid Host Antibody Response toward the Development of Second Generation Gene Delivery Vectors.

Tseng YS, Agbandje-McKenna M.

Front Immunol. 2014 Jan 30;5:9. doi: 10.3389/fimmu.2014.00009. eCollection 2014. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk